Cargando…
Cartilage Oligomeric Matrix Protein (COMP)-Mediated Cell Differentiation to Proteolysis Mechanism Networks from Human Normal Adjacent Tissues to Lung Adenocarcinoma
Background: To understand cartilage oligomeric matrix protein (COMP) mechanism network from human normal adjacent tissues to lung adenocarcinoma. Methods: COMP complete different activated (all no positive correlation, Pearson CC< 0.25) and uncomplete (partly no positive correlation except COMP,...
Autores principales: | Wang, Lin, Huang, Juxiang, Jiang, Minghu, Diao, Haizhen, Zhou, Huilei, Li, Xiaohe, Chen, Qingchun, Jiang, Zhenfu, Feng, Haitao, Wolfl, Stefan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
IOS Press
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4605476/ https://www.ncbi.nlm.nih.gov/pubmed/24064399 http://dx.doi.org/10.3233/ACP-130084 |
Ejemplares similares
-
Activated amelogenin Y-linked (AMELY) regulation and angiogenesis in human hepatocellular carcinoma by biocomputation
por: QI, LIANXIU, et al.
Publicado: (2013) -
Cartilage Oligomeric Matrix Protein (COMP): A Biomarker of Arthritis
por: Tseng, Susan, et al.
Publicado: (2009) -
Cartilage oligomeric matrix protein (COMP) in murine brachiocephalic and carotid atherosclerotic lesions
por: Bond, Andrew R., et al.
Publicado: (2014) -
Relationship between cartilage oligomeric matrix protein (COMP) and rheumatoid arthritis severity
por: Saghafi, Massoud, et al.
Publicado: (2017) -
Serum cartilage oligomeric matrix protein (COMP) decreases in rheumatoid arthritis patients treated with infliximab or etanercept
por: Crnkic, Meliha, et al.
Publicado: (2003)